These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 26444325)

  • 21. CYP24A1 as a potential target for cancer therapy.
    Sakaki T; Yasuda K; Kittaka A; Yamamoto K; Chen TC
    Anticancer Agents Med Chem; 2014 Jan; 14(1):97-108. PubMed ID: 23869781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multifunctional and potent roles of the 3-hydroxypropoxy group provide eldecalcitol's benefit in osteoporosis treatment.
    Ono Y
    J Steroid Biochem Mol Biol; 2014 Jan; 139():88-97. PubMed ID: 24139874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Opposite effects of arsenic trioxide on the Nrf2 pathway in oral squamous cell carcinoma in vitro and in vivo.
    Zhang X; Su Y; Zhang M; Sun Z
    Cancer Lett; 2012 May; 318(1):93-8. PubMed ID: 22155346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 19-nor-26,27-bishomo-vitamin D3 analogs: a unique class of potent inhibitors of proliferation of prostate, breast, and hematopoietic cancer cells.
    Kubota T; Koshizuka K; Koike M; Uskokovic M; Miyoshi I; Koeffler HP
    Cancer Res; 1998 Aug; 58(15):3370-5. PubMed ID: 9699668
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Temporal changes in tissue 1α,25-dihydroxyvitamin D3, vitamin D receptor target genes, and calcium and PTH levels after 1,25(OH)2D3 treatment in mice.
    Chow EC; Quach HP; Vieth R; Pang KS
    Am J Physiol Endocrinol Metab; 2013 May; 304(9):E977-89. PubMed ID: 23482451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progestins inhibit calcitriol-induced CYP24A1 and synergistically inhibit ovarian cancer cell viability: An opportunity for chemoprevention.
    Rodriguez GC; Turbov J; Rosales R; Yoo J; Hunn J; Zappia KJ; Lund K; Barry CP; Rodriguez IV; Pike JW; Conrads TP; Darcy KM; Maxwell GL; Hamilton CA; Syed V; Thaete LG
    Gynecol Oncol; 2016 Oct; 143(1):159-167. PubMed ID: 27106018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined cetuximab and genistein treatment shows additive anti-cancer effect on oral squamous cell carcinoma.
    Park SJ; Kim MJ; Kim YK; Kim SM; Park JY; Myoung H
    Cancer Lett; 2010 Jun; 292(1):54-63. PubMed ID: 19959278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 22-Oxa-1alpha,25-dihydroxyvitamin D3 inhibits metastasis and angiogenesis in lung cancer.
    Nakagawa K; Sasaki Y; Kato S; Kubodera N; Okano T
    Carcinogenesis; 2005 Jun; 26(6):1044-54. PubMed ID: 15718253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of cepharanthine alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
    Harada K; Ferdous T; Itashiki Y; Takii M; Mano T; Mori Y; Ueyama Y
    Anticancer Res; 2009 Apr; 29(4):1263-70. PubMed ID: 19414373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PKPD modelling to predict altered disposition of 1α,25-dihydroxyvitamin D3 in mice due to dose-dependent regulation of CYP27B1 on synthesis and CYP24A1 on degradation.
    Quach HP; Yang QJ; Chow EC; Mager DE; Hoi SY; Pang KS
    Br J Pharmacol; 2015 Jul; 172(14):3611-26. PubMed ID: 25829051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of combination treatment with a vitamin D analog (OCT) and a bisphosphonate (AHPrBP) in a nude mouse model of cancer-associated hypercalcemia.
    Endo K; Katsumata K; Iguchi H; Kubodera N; Teramoto T; Ikeda K; Fujita T; Ogata E
    J Bone Miner Res; 1998 Sep; 13(9):1378-83. PubMed ID: 9738509
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-invasion and anti-tumor growth effect of doxycycline treatment for human oral squamous-cell carcinoma--in vitro and in vivo studies.
    Shen LC; Chen YK; Lin LM; Shaw SY
    Oral Oncol; 2010 Mar; 46(3):178-84. PubMed ID: 20036604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel vitamin D3 analog, 22-oxa-1,25-dihydroxyvitamin D3, inhibits the growth of human breast cancer in vitro and in vivo without causing hypercalcemia.
    Abe J; Nakano T; Nishii Y; Matsumoto T; Ogata E; Ikeda K
    Endocrinology; 1991 Aug; 129(2):832-7. PubMed ID: 1855478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy.
    Díaz GD; Paraskeva C; Thomas MG; Binderup L; Hague A
    Cancer Res; 2000 Apr; 60(8):2304-12. PubMed ID: 10786699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic stability of 3-epi-1α,25-dihydroxyvitamin D3 over 1 α 25-dihydroxyvitamin D3: metabolism and molecular docking studies using rat CYP24A1.
    Rhieu SY; Annalora AJ; Wang G; Flarakos CC; Gathungu RM; Vouros P; Sigüeiro R; Mouriño A; Schuster I; Palmore GT; Reddy GS
    J Cell Biochem; 2013 Oct; 114(10):2293-305. PubMed ID: 23606409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acidosis enhances the self-renewal and mitochondrial respiration of stem cell-like glioma cells through CYP24A1-mediated reduction of vitamin D.
    Hu P; Li S; Tian N; Wu F; Hu Y; Li D; Qi Y; Wei Z; Wei Q; Li Y; Yin B; Jiang T; Yuan J; Qiang B; Han W; Peng X
    Cell Death Dis; 2019 Jan; 10(1):25. PubMed ID: 30631035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of 19-nor-2alpha-(3-hydroxypropyl)-1alpha,25-dihydroxyvitamin D3 as a therapeutic agent for androgen-dependent prostate cancer.
    Flanagan JN; Zheng S; Chiang KC; Kittaka A; Sakaki T; Nakabayashi S; Zhao X; Spanjaard RA; Persons KS; Mathieu JS; Holick MF; Chen TC
    Anticancer Res; 2009 Sep; 29(9):3547-53. PubMed ID: 19667147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Iron Chelator, Dp44mT, Effectively Inhibits Human Oral Squamous Cell Carcinoma Cell Growth in Vitro and in Vivo.
    Lee JC; Chiang KC; Feng TH; Chen YJ; Chuang ST; Tsui KH; Chung LC; Juang HH
    Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27589737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolism of 20-hydroxyvitamin D3 and 20,23-dihydroxyvitamin D3 by rat and human CYP24A1.
    Tieu EW; Li W; Chen J; Kim TK; Ma D; Slominski AT; Tuckey RC
    J Steroid Biochem Mol Biol; 2015 May; 149():153-65. PubMed ID: 25727742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preclinical Prevention Trial of Calcitriol: Impact of Stage of Intervention and Duration of Treatment on Oral Carcinogenesis.
    Vincent-Chong VK; DeJong H; Attwood K; Hershberger PA; Seshadri M
    Neoplasia; 2019 Apr; 21(4):376-388. PubMed ID: 30875566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.